A detailed history of Nordea Investment Management Ab transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Nordea Investment Management Ab holds 279,714 shares of AMPH stock, worth $9.99 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
279,714
Previous 266,863 4.82%
Holding current value
$9.99 Million
Previous $13 Million 19.81%
% of portfolio
0.01%
Previous 0.02%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 06, 2025

BUY
$36.84 - $53.4 $473,430 - $686,243
12,851 Added 4.82%
279,714 $10.4 Million
Q3 2024

Nov 05, 2024

SELL
$36.99 - $50.09 $507,539 - $687,284
-13,721 Reduced 4.89%
266,863 $13 Million
Q2 2024

Aug 08, 2024

SELL
$38.65 - $43.48 $2.03 Million - $2.28 Million
-52,430 Reduced 15.74%
280,584 $11.2 Million
Q1 2024

May 02, 2024

BUY
$42.85 - $63.45 $51,805 - $76,711
1,209 Added 0.36%
333,014 $14.6 Million
Q4 2023

Jan 10, 2024

SELL
$44.49 - $62.93 $295,324 - $417,729
-6,638 Reduced 1.96%
331,805 $20.5 Million
Q3 2023

Nov 13, 2023

SELL
$45.51 - $65.0 $15,882 - $22,685
-349 Reduced 0.1%
338,443 $15.6 Million
Q2 2023

Jul 07, 2023

BUY
$35.77 - $58.38 $306,870 - $500,842
8,579 Added 2.6%
338,792 $19.5 Million
Q1 2023

Apr 19, 2023

SELL
$27.99 - $37.92 $201,919 - $273,554
-7,214 Reduced 2.14%
330,213 $12.4 Million
Q4 2022

Feb 08, 2023

SELL
$27.93 - $31.27 $222,071 - $248,627
-7,951 Reduced 2.3%
337,427 $9.45 Million
Q3 2022

Oct 19, 2022

SELL
$27.56 - $37.75 $38,666 - $52,963
-1,403 Reduced 0.4%
345,378 $10.1 Million
Q2 2022

Aug 09, 2022

BUY
$29.79 - $42.29 $1.86 Million - $2.64 Million
62,390 Added 21.94%
346,781 $11.9 Million
Q1 2022

Apr 11, 2022

BUY
$22.96 - $36.45 $250,975 - $398,434
10,931 Added 4.0%
284,391 $10.4 Million
Q4 2021

Jan 20, 2022

SELL
$18.14 - $23.29 $79,126 - $101,590
-4,362 Reduced 1.57%
273,460 $6.45 Million
Q3 2021

Nov 01, 2021

SELL
$17.83 - $21.49 $4.95 Million - $5.97 Million
-277,822 Reduced 50.0%
277,822 $5.38 Million
Q3 2021

Nov 01, 2021

BUY
$17.83 - $21.49 $4.89 Million - $5.9 Million
274,476 Added 97.62%
555,644 $10.6 Million
Q2 2021

Jul 16, 2021

BUY
$17.11 - $20.92 $456,802 - $558,522
26,698 Added 10.49%
281,168 $5.67 Million
Q1 2021

May 17, 2021

SELL
$17.21 - $20.65 $105,032 - $126,026
-6,103 Reduced 2.34%
254,470 $4.6 Million
Q4 2020

Feb 12, 2021

SELL
$17.76 - $21.24 $104,091 - $124,487
-5,861 Reduced 2.2%
260,573 $5.24 Million
Q3 2020

Nov 09, 2020

SELL
$17.99 - $22.22 $4.71 Million - $5.82 Million
-262,064 Reduced 49.59%
266,434 $4.97 Million
Q2 2020

Aug 13, 2020

BUY
$14.25 - $22.46 $3.74 Million - $5.9 Million
262,800 Added 98.91%
528,498 $11.9 Million
Q1 2020

May 15, 2020

BUY
$12.66 - $20.08 $187,443 - $297,304
14,806 Added 5.9%
265,698 $4.03 Million
Q4 2019

Feb 11, 2020

BUY
$17.07 - $20.64 $9,610 - $11,620
563 Added 0.22%
250,892 $4.85 Million
Q3 2019

Nov 13, 2019

BUY
$19.12 - $22.62 $131,029 - $155,014
6,853 Added 2.81%
250,329 $5.09 Million
Q2 2019

Aug 14, 2019

SELL
$18.92 - $22.96 $200,457 - $243,261
-10,595 Reduced 4.17%
243,476 $5.14 Million
Q1 2019

May 20, 2019

BUY
$19.46 - $25.28 $84,514 - $109,791
4,343 Added 1.74%
254,071 $5.19 Million
Q4 2018

Feb 14, 2019

BUY
$17.72 - $22.51 $187,282 - $237,908
10,569 Added 4.42%
249,728 $4.97 Million
Q3 2018

Nov 14, 2018

BUY
$15.39 - $19.38 $1 Million - $1.26 Million
65,160 Added 37.45%
239,159 $4.6 Million
Q2 2018

Aug 13, 2018

BUY
$14.63 - $19.6 $92,578 - $124,028
6,328 Added 3.77%
173,999 $2.66 Million
Q1 2018

May 14, 2018

BUY
$17.23 - $20.35 $647,744 - $765,037
37,594 Added 28.9%
167,671 $3.14 Million
Q4 2017

Feb 12, 2018

BUY
$17.76 - $19.75 $18,310 - $20,362
1,031 Added 0.8%
130,077 $2.5 Million
Q3 2017

Nov 09, 2017

BUY
$14.73 - $17.99 $1.9 Million - $2.32 Million
129,046
129,046 $2.31 Million

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $1.75B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Nordea Investment Management Ab Portfolio

Follow Nordea Investment Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Nordea Investment Management Ab with notifications on news.